Clinical data mining: challenges, opportunities, and recommendations for translational applications

被引:2
作者
Qiao, Huimin [1 ]
Chen, Yijing [2 ]
Qian, Changshun [3 ]
Guo, You [1 ,2 ,3 ,4 ]
机构
[1] Gannan Med Univ, Affiliated Hosp 1, Med Big Data & Bioinformat Res Ctr, Ganzhou, Peoples R China
[2] Gannan Med Univ, Sch Publ Hlth & Hlth Management, Ganzhou, Peoples R China
[3] Jiangxi Univ Sci & Technol, Sch Informat Engn, Ganzhou, Peoples R China
[4] Ganzhou Key Lab Med Big Data, Ganzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Clinical data mining; Transformative application; Heterogeneity; Analytic workflow; Predictive model; FALSE DISCOVERY RATE; MENDELIAN RANDOMIZATION; STATISTICAL CONSIDERATIONS; SUBGROUP ANALYSIS; LUNG-CANCER; BIG DATA; TRIALS; SCORE; RISK; ASSOCIATION;
D O I
10.1186/s12967-024-05005-0
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Clinical data mining of predictive models offers significant advantages for re-evaluating and leveraging large amounts of complex clinical real-world data and experimental comparison data for tasks such as risk stratification, diagnosis, classification, and survival prediction. However, its translational application is still limited. One challenge is that the proposed clinical requirements and data mining are not synchronized. Additionally, the exotic predictions of data mining are difficult to apply directly in local medical institutions. Hence, it is necessary to incisively review the translational application of clinical data mining, providing an analytical workflow for developing and validating prediction models to ensure the scientific validity of analytic workflows in response to clinical questions. This review systematically revisits the purpose, process, and principles of clinical data mining and discusses the key causes contributing to the detachment from practice and the misuse of model verification in developing predictive models for research. Based on this, we propose a niche-targeting framework of four principles: Clinical Contextual, Subgroup-Oriented, Confounder- and False Positive-Controlled (CSCF), to provide guidance for clinical data mining prior to the model's development in clinical settings. Eventually, it is hoped that this review can help guide future research and develop personalized predictive models to achieve the goal of discovering subgroups with varied remedial benefits or risks and ensuring that precision medicine can deliver its full potential.
引用
收藏
页数:17
相关论文
共 175 条
  • [51] Artificial intelligence to enhance clinical value across the spectrum of cardiovascular healthcare
    Gill, Simrat K.
    Karwath, Andreas
    Uh, Hae-Won
    Cardoso, Victor Roth
    Gu, Zhujie
    Barsky, Andrey
    Slater, Luke
    Acharjee, Animesh
    Duan, Jinming
    Dall'Olio, Lorenzo
    El Bouhaddani, Said
    Chernbumroong, Saisakul
    Stanbury, Mary
    Haynes, Sandra
    Asselbergs, Folkert W.
    Grobbee, Diederick E.
    Eijkemans, Marinus J. C.
    Gkoutos, Georgios, V
    Kotecha, Dipak
    [J]. EUROPEAN HEART JOURNAL, 2023, 44 (09) : 713 - 725
  • [52] Institutionalising community engagement for quality of care: moving beyond the rhetoric
    Gilmore, Brynne
    Dsane-Aidoo, Paul Henry
    Rosato, Mikey
    Yaqub, Nuhu Omeiza
    Doe, Roseline
    Baral, Sushil
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2023, 381 : e072638
  • [53] False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies
    Glickman, Mark E.
    Rao, Sowmya R.
    Schultz, Mark R.
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2014, 67 (08) : 850 - 857
  • [54] Multiple comparisons, explained
    Goodman, SN
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1998, 147 (09) : 807 - 812
  • [55] Optimized multiple testing procedures for nested sub-populations based on a continuous biomarker
    Graf, Alexandra Christine
    Magirr, Dominic
    Dmitrienko, Alex
    Posch, Martin
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2020, 29 (10) : 2945 - 2957
  • [56] Gunashova G.Y., 2022, Adv. Biol. Earth Sci., V7, P198
  • [57] Prevention of venous thromboembolism in patients with cancer
    Guntupalli, Saketh R.
    Spinosa, Daniel
    Wethington, Stephanie
    Eskander, Ramez
    Khorana, Alok A.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2023, 381
  • [58] Falsification of the instrumental variable conditions in Mendelian randomization studies in the UK Biobank
    Guo, Kelly
    Diemer, Elizabeth W.
    Labrecque, Jeremy A.
    Swanson, Sonja A.
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2023, 38 (09) : 921 - 927
  • [59] A qualitative signature for predicting pathological response to neoadjuvant chemoradiation in locally advanced rectal cancers
    Guo, You
    Jiang, Weizhong
    Ao, Lu
    Song, Kai
    Chen, Huxing
    Guan, Qingzhou
    Gao, Qiao
    Cheng, Jun
    Liu, Huaping
    Wang, Xianlong
    Guan, Guoxian
    Guo, Zheng
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 129 (01) : 149 - 153
  • [60] Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma
    Hall, William A.
    Li, Jiahe
    You, Y. Nancy
    Gollub, Marc J.
    Grajo, Joseph R.
    Rosen, Mark
    Deprisco, Greg
    Yothers, Greg
    Dorth, Jennifer A.
    Rahma, Osama E.
    Russell, Marcia M.
    Gross, Howard M.
    Jacobs, Samuel A.
    Faller, Bryan A.
    George, Sagila
    Al Baghdadi, Tareq
    Haddock, Michael G.
    Valicenti, Richard
    Hong, Theodore S.
    George, Thomas J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (29) : 4643 - +